Sign in

NeueHealth (NEUE)

Q2 2025 Earnings Summary

Reported on Jan 1, 1970
Pre-Earnings PriceN/ADate unavailable
Post-Earnings PriceN/ADate unavailable
Price ChangeN/A
MetricYoY ChangeReason

ACO REACH Revenue (Q1 2024)

-28.4% / -$68.0 million

The revenue drop was driven by a reduction of approximately 23,000 beneficiaries aligned to REACH ACOs, reflecting a shift in the underlying membership base and impacting overall revenue streams.

Total Revenue (Q1 2024)

Decreased from $300.6M to $245.1M

Overall revenue declined primarily due to lower ACO REACH performance and moderately lower volume in the NeueCare segment, despite a 24.1% increase in capitated revenue that was partly offset by a decline in service revenue.

ACO REACH Revenue (Q1 2025)

Decrease of $47.8 million

A further reduction in beneficiaries (approximately 13,000) and a strategic shift in membership mix away from REACH ACOs contributed significantly to the decline in ACO REACH revenue compared to the prior period.

Capitated Revenue (Q1 2025)

+31.8% / +$19.5 million

Increased membership through third-party payor contracts led to a strong growth in capitated revenue, partially mitigating the overall revenue decline from other segments.

Service Revenue (Q1 2025)

Decreased by $1.8 million

The decline in service revenue was primarily driven by the sale of AMD in November 2024, reflecting a one-time adjustment impacting the revenue mix in the subsequent period.

Research analysts covering NeueHealth.